Cleveland Clinic Foundation, Heart Vascular Institute, Cleveland, Ohio.
University of Michigan, Ann Arbor, Michigan.
J Am Coll Cardiol. 2020 May 26;75(20):2602-2618. doi: 10.1016/j.jacc.2020.03.060.
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for women in the United States and worldwide. There has been no American College of Cardiology (ACC)/American Heart Association guideline update specifically for the prevention of CVD in women since 2011. Since then, the body of sex-specific data has grown, in addition to updated hypertension, cholesterol, diabetes, atrial fibrillation, and primary prevention guidelines. The ACC CVD in Women Committee undertook a review of the recent guidelines and major studies to summarize recommendations pertinent to women. In this update, the authors address special topics, particularly the risk factors and treatments that have led to some controversies and confusion. Specifically, sex-related risk factors, hypertension, diabetes, hyperlipidemia, anticoagulation for atrial fibrillation, use of aspirin, perimenopausal hormone therapy, and psychosocial issues are highlighted.
心血管疾病(CVD)仍然是美国和全球女性发病率和死亡率的主要原因。自 2011 年以来,美国心脏病学会(ACC)/美国心脏协会(AHA)尚未发布专门针对女性 CVD 预防的指南更新。此后,除了更新的高血压、胆固醇、糖尿病、心房颤动和一级预防指南外,还增加了大量特定于性别的数据。ACC 女性心血管疾病委员会对最近的指南和主要研究进行了审查,以总结与女性相关的建议。在本次更新中,作者讨论了一些特别的主题,特别是导致一些争议和困惑的危险因素和治疗方法。具体而言,突出强调了与性别相关的危险因素、高血压、糖尿病、血脂异常、心房颤动的抗凝治疗、阿司匹林的使用、围绝经期激素治疗以及心理社会问题。